The FDA approved Sanofi SA’s Admelog Monday, which is a biosimilar of Eli Lilly’s fast-acting insulin. Here are four things to know. 1. Admelog was approved to control blood sugar levels after eating ...

The use of abbreviated pathways can reduce drug development costs so products can be offered at a lower price to patients. The Food and Drug Administration (FDA) announced the final approval of ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

The FDA granted final approval of Sanofi’s 505(b)(2) application for Admelog yesterday. According to the FDA, Admelog is a follow-on product that, for approval, relied in part on FDA’s finding of ...

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with ...

Nurse giving blood sugar test to patient in home This study builds on recent research indicating that prescribing NPH insulin may be reasonable for older patients with concerns about medication costs, ...